ARMS
APSAC Reocclusion Multicentre Study


Purpose
To investigate the effects of anisoylated plasminogen streptokinase activator complex (APSAC or anistreplase) on coronary artery patency following AMI

References
Relik-van Wely L, Visser RF, et al: Angiographically assessed coronary arterial patency and reocclusion in patients with acute myocardial infarction treated with anistreplase: results of the anistreplase reocclusion multicenter study (ARMS). Am J Cardiol 1991, 68:296–300.

Voltar

Apoio: Libbs Farmacêutica Farmacêutica